Convergent Dental Inc.
$6.5M 162 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
Bard Peripheral Vascular, Inc.
Bard Peripheral Vascular, Inc. reported $6,519,561.49 across General Payments, Research, and Ownership to 8,034 physicians and teaching hospitals across 8,183 transactions.
- $6.5M
- All-tracks total
- 8,183
- Transactions
- 8,034
- Recipients
- +$471.1K
- General Payments vs PY2023
Bard Peripheral Vascular, Inc. reported $6,519,561.49 across all CMS Open Payments tracks (General + Research + Ownership) to 8,034 physicians and teaching hospitals in Program Year 2024 - ranking #229 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $4,565,271.95, averaging $811.50 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer bard-peripheral-vascular-inc Bard Peripheral Vascular, Inc.
$6.5M · #229/1,925 · 0.0% industry · PY2024
- TOT $6.5M
- RANK #229
- SHARE 0.0%
- TXN 8,183
- RCP 8,034
- CAT 9
- GEN $4.6M
- ΔGEN +$471.1K
- TOP1 51.6%
- PY 2024
Volume peers
Nearest volume peer: Convergent Dental Inc. ($6.5M)
Bard Peripheral Vascular, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
Bard Peripheral Vascular, Inc.'s CMS-reported General Payments increased by $471.1K (+11.5%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: BARD PERIPHERAL VASCULAR, INC.PY2023: BARD PERIPHERAL VASCULAR, INC.PY2024: Bard Peripheral Vascular, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $4,094,205.85
- PY2024
- $4,565,271.95
What the Data Shows for Bard Peripheral Vascular, Inc.
In Program Year 2024, Bard Peripheral Vascular, Inc. reported $6,519,561.49 in payments to 8,034 physicians and teaching hospitals across 8,183 individual transactions, an average of $796.72 per transaction and $811.50 per recipient. That total places Bard Peripheral Vascular, Inc. at rank #229 out of 1,925 companies in the CMS Open Payments database, a comparatively small 0.0% slice of all industry payments reported nationwide for the year.
The 9-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Royalty or License" at $2.4M, accounting for 52.4% of this company's General Payments and 5 transactions.
General Payment Breakdown by Type
Across 9 types of general payments, Bard Peripheral Vascular, Inc.'s largest category was "Royalty or License" at $2.4M - 52.4% of General Payments.
Bard Peripheral Vascular, Inc. reports 9 general-payment categories - the top three are Royalty or License (52.4%), Consulting Fee (26.3%), and Food and Beverage (7.2%). The remaining 6 categories make up 14.1% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
Category breadth matters here: Bard Peripheral Vascular, Inc. files across 9 named CMS general-payment types in Program Year 2024, versus manufacturers that report a single dominant category. The chart and table below enumerate every type with an amount above zero for this company.
How Bard Peripheral Vascular, Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Royalty or License | $2.4M | 5 | 52.4% |
| Consulting Fee | $1.2M | 447 | 26.3% |
| Food and Beverage | $330.8K | 6,930 | 7.2% |
| Debt Forgiveness | $195.1K | 6 | 4.3% |
| Travel and Lodging | $186.6K | 494 | 4.1% |
| Honoraria | $111.4K | 65 | 2.4% |
| Education | $91.1K | 64 | 2.0% |
| Long-Term Medical Supply or Device Loan | $53.9K | 22 | 1.2% |
| Grant | $5.0K | 1 | 0.1% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $2,716,395.30 (59.5%) of $4,565,271.95 in this company's General Payments records across 3,863 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Bard Peripheral Vascular, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Richard Chesbrough
$2,356,281.00 across 4 reported transactions
- 2
Wadley Regional Medical Center
$168,680.19 across 1 reported transactions
- 3
Robert Lewandowski
$64,418.30 across 21 reported transactions
- 4
Ziv Haskal
$63,865.29 across 16 reported transactions
- 5
Riad Salem
$63,150.52 across 33 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Bard Peripheral Vascular, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Bard Peripheral Vascular, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Bard Peripheral Vascular, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Arcutis Biotherapeutics, Inc.
$6.6M 47,756 recipients
Compare payment profiles
Mylan Inc.
$6.4M 305 recipients
Compare payment profiles
Baxter Healthcare
$6.4M 26,086 recipients
Compare payment profiles
GLW, Inc
$6.7M 11 recipients
Compare payment profiles
PharmaEssentia USA Corporation
$6.3M 4,725 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.